Vicks Vaporub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to minor throat and bronchial irritation associated with the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains of muscles and joints when applied to the affected areas.

Limitations of Use: There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended method for cough suppression involves applying a thick layer of the product to the throat and chest. If desired, the area may be covered with a warm, dry cloth to enhance the effect. It is advised to keep clothing loose around the throat and chest to facilitate the release of vapors to the nose and mouth. This application may be performed up to three times daily or as directed by a healthcare professional.

For the relief of minor aches and pains in muscles and joints, the product should be applied to the affected area no more than 3 to 4 times daily.

The product is not recommended for use in children under 2 years of age.

Contraindications

Use of this product is contraindicated in the following situations:

Administration by mouth, application in nostrils, or use on wounds or damaged skin is prohibited due to the potential for adverse effects. Additionally, the application of tight bandages is not recommended, as it may interfere with the product's efficacy and safety.

Heating, microwaving, or adding the product to hot water or any container with heated water is contraindicated. Such actions may lead to splattering, which poses a risk of burns.

Warnings and Precautions

For external use only; direct contact with the eyes must be avoided to prevent irritation or injury.

Healthcare professionals should advise patients to discontinue use and seek medical attention if any of the following occur: if muscle aches and pains worsen or persist for more than 7 days, or if they resolve and then recur within a few days. Additionally, if a cough persists for more than one week, recurs, or is accompanied by fever, rash, or a persistent headache, patients should be instructed to consult a physician. A persistent cough may indicate an underlying serious condition that requires further evaluation.

Side Effects

Patients using this product should be aware of certain adverse reactions and warnings associated with its use. This product is intended for external use only, and contact with the eyes should be avoided to prevent irritation.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if they experience muscle aches and pains that worsen or persist for more than 7 days, or if these symptoms resolve and then recur within a few days. Additionally, if a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache, it is important to seek medical advice, as a persistent cough may indicate a serious underlying condition.

Before using this product, patients should consult a healthcare provider if they have a cough that occurs with excessive phlegm (mucus) or if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. These considerations are crucial for ensuring the safe and effective use of the product.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Vicks Vaporub (camphor (synthetic) , eucalyptus oil, and menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product. For children aged 2 years and older, it is indicated for cough suppression. A thick layer should be applied to the throat and chest, and it may be covered with a warm, dry cloth if desired. Clothing around the throat and chest should be kept loose to facilitate the inhalation of vapors. This application can be performed up to three times daily or as directed by a healthcare professional.

For the relief of minor aches and pains in muscles and joints, the product may be applied to the affected area no more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is recommended to ensure optimal patient care and safety.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology. As such, the assessment of these aspects remains incomplete.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and respiratory issues. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be instructed not to use the product by mouth, in nostrils, on wounds, or on damaged skin. It is important to inform patients that the product should not be used with tight bandages.

Patients should be counseled to stop using the product and consult a doctor if muscle aches and pains worsen or persist for more than 7 days, or if they clear up and then occur again within a few days. Additionally, they should be advised to seek medical attention if a cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious condition.

When using this product, patients must be cautioned against heating it, microwaving it, or adding it to hot water or any container where water is being heated, as this may cause splattering and result in burns. Furthermore, patients should be encouraged to ask a doctor before use if they have a cough that occurs with excessive phlegm (mucus) or if they have a persistent or chronic cough associated with smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The product is administered topically, with specific instructions for use depending on the indication. For cough suppression, patients should apply a thick layer to the throat and chest, optionally covering it with a warm, dry cloth, and ensuring clothing is loose to facilitate vapor inhalation. This application can be repeated up to three times daily or as directed by a healthcare provider. For relief of minor aches and pains in muscles or joints, the product should be applied to the affected area no more than 3 to 4 times daily.

Clinicians should counsel patients to consult a healthcare professional if they are pregnant or breastfeeding before use. It is important to keep the product out of reach of children, and in the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Vicks Vaporub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)